Rafferty Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.74M | Buy |
598,231
+95,280
| +19% | +$1.07M | 0.02% | 342 |
|
|
2025
Q1 | $5.07M | Sell |
502,951
-219,478
| -30% | -$2.21M | 0.02% | 367 |
|
|
2024
Q4 | $8.55M | Buy |
722,429
+55,960
| +8% | +$662K | 0.03% | 311 |
|
|
2024
Q3 | $7.69M | Sell |
666,469
-211,240
| -24% | -$2.44M | 0.03% | 326 |
|
|
2024
Q2 | $9.28M | Sell |
877,709
-34,484
| -4% | -$364K | 0.03% | 296 |
|
|
2024
Q1 | $9.61M | Sell |
912,193
-60,941
| -6% | -$642K | 0.04% | 275 |
|
|
2023
Q4 | $10.9M | Buy |
973,134
+195,136
| +25% | +$2.19M | 0.05% | 252 |
|
|
2023
Q3 | $9.09M | Sell |
777,998
-14,633
| -2% | -$171K | 0.05% | 248 |
|
|
2023
Q2 | $7.99M | Sell |
792,631
-56,075
| -7% | -$565K | 0.05% | 281 |
|
|
2023
Q1 | $6.26M | Buy |
848,706
+482,095
| +132% | +$3.56M | 0.04% | 331 |
|
|
2022
Q4 | $2.93M | Buy |
366,611
+218,279
| +147% | +$1.74M | 0.02% | 490 |
|
|
2022
Q3 | $478K | Buy |
148,332
+118,094
| +391% | +$381K | 0.01% | 864 |
|
|
2022
Q2 | $123K | Buy |
+30,238
| New | +$123K | ﹤0.01% | 1061 |
|